These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 22008644)
1. General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option? Fujiki M; Aucejo F; Kim R Liver Int; 2011 Sep; 31(8):1081-9. PubMed ID: 22008644 [TBL] [Abstract][Full Text] [Related]
2. Is the treatment of hepatocellular carcinoma on the waiting list necessary? Majno P; Lencioni R; Mornex F; Girard N; Poon RT; Cherqui D Liver Transpl; 2011 Oct; 17 Suppl 2():S98-108. PubMed ID: 21954097 [No Abstract] [Full Text] [Related]
3. Current controversies surrounding liver transplantation for hepatocellular carcinoma. Silva MF; Wigg AJ J Gastroenterol Hepatol; 2010 Jul; 25(7):1217-26. PubMed ID: 20594247 [TBL] [Abstract][Full Text] [Related]
4. Selection of candidates with HCC for transplantation in the MELD era. Sala M; Varela M; Bruix J Liver Transpl; 2004 Oct; 10(10 Suppl 2):S4-9. PubMed ID: 15382217 [TBL] [Abstract][Full Text] [Related]
5. Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma? Yao FY; Breitenstein S; Broelsch CE; Dufour JF; Sherman M Liver Transpl; 2011 Oct; 17 Suppl 2():S109-16. PubMed ID: 21584927 [No Abstract] [Full Text] [Related]
7. Hepatocellular carcinoma: current management and perspectives for the future. Rahbari NN; Mehrabi A; Mollberg NM; Müller SA; Koch M; Büchler MW; Weitz J Ann Surg; 2011 Mar; 253(3):453-69. PubMed ID: 21263310 [TBL] [Abstract][Full Text] [Related]
8. The best candidates for transarterial chemotherapy in patients with hepatocellular carcinoma awaiting liver transplantation: a cohort-based characterization of dropout times. Jang JW; Choi JY; Bae SH; Kim CW; Cho SH; Yoon SK; Yang JM; Han JY; Lee YS; Kim DG Aliment Pharmacol Ther; 2007 Jul; 26(1):87-94. PubMed ID: 17555425 [TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate. Cescon M; Cucchetti A; Ravaioli M; Pinna AD J Hepatol; 2013 Mar; 58(3):609-18. PubMed ID: 23041304 [TBL] [Abstract][Full Text] [Related]
10. Surgery and transplantation for hepatocellular cancer. Wall WJ; Marotta PJ Liver Transpl; 2000 Nov; 6(6 Suppl 2):S16-22. PubMed ID: 11084080 [TBL] [Abstract][Full Text] [Related]
11. Liver transplantation in a patient treated by sorafenib for hepatocellular carcinoma. Borentain P; Gregoire E; Hardwigsen J; Garcia S; Durieux O; Le Treut YP; Gérolami R Clin Res Hepatol Gastroenterol; 2011 Mar; 35(3):234-6. PubMed ID: 21345761 [TBL] [Abstract][Full Text] [Related]
12. Review of outcomes of primary liver cancers in children: our institutional experience with resection and transplantation. Malek MM; Shah SR; Atri P; Paredes JL; DiCicco LA; Sindhi R; Soltys KA; Mazariegos GV; Kane TD Surgery; 2010 Oct; 148(4):778-82; discussion 782-4. PubMed ID: 20728194 [TBL] [Abstract][Full Text] [Related]
13. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395 [TBL] [Abstract][Full Text] [Related]
19. Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Porrett PM; Peterman H; Rosen M; Sonnad S; Soulen M; Markmann JF; Shaked A; Furth E; Reddy KR; Olthoff K Liver Transpl; 2006 Apr; 12(4):665-73. PubMed ID: 16482577 [TBL] [Abstract][Full Text] [Related]
20. [Can adjuvant chemotherapy of hepatocellular carcinoma improve results of liver transplantation?]. Burtin P Gastroenterol Clin Biol; 1993; 17(10):776-7. PubMed ID: 8288099 [No Abstract] [Full Text] [Related] [Next] [New Search]